Works matching IS 11738804 AND DT 2022 AND VI 36 AND IP 4

Results: 10
    1

    Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study).

    Published in:
    BioDrugs, 2022, v. 36, n. 4, p. 509, doi. 10.1007/s40259-022-00543-9
    By:
    • Sáez-Peñataro, Joaquín;
    • Torres, Ferran;
    • Bartra, Joan;
    • Bascuas, Juan;
    • Vilella, Anna;
    • Tortajada, Marta;
    • Quesada, Sebastiana;
    • González, Elisenda;
    • López-Suñé, Ester;
    • Castells, Antoni;
    • Serrano, Sandra;
    • Camacho, Concepción;
    • Trilla, Antoni;
    • Calvo, Gonzalo;
    • the VigilVacCOVID Group;
    • Sáez-Peñataro, Joaquin;
    • Bertran, Maria-Jesús;
    • Carrera, Cristina;
    • Galisteo, Maria;
    • Gómez, Sara
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.

    Published in:
    BioDrugs, 2022, v. 36, n. 4, p. 443, doi. 10.1007/s40259-022-00536-8
    By:
    • Luxi, Nicoletta;
    • Giovanazzi, Alexia;
    • Arcolaci, Alessandra;
    • Bonadonna, Patrizia;
    • Crivellaro, Maria Angiola;
    • Cutroneo, Paola Maria;
    • Ferrajolo, Carmen;
    • Furci, Fabiana;
    • Guidolin, Lucia;
    • Moretti, Ugo;
    • Olivieri, Elisa;
    • Petrelli, Giuliana;
    • Zanoni, Giovanna;
    • Senna, Gianenrico;
    • Trifirò, Gianluca
    Publication type:
    Article